Cat.#: ACPP-1301
| Despition | SHISA9 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1456 | Human HEXA Protein (AC1456) | 5 µg | inquiry |
| ACPP-1158 | Synthetic Nanodisc Human MC4-R Protein (AC1158) | 10 µg | inquiry |
| ACPP-1065 | Recombinant Human Prostate Specific Antigen Protein (Fc Tag) (AC1065) | 50 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1711 | Human PEBP1 Protein (AC1711) | 10 µg | inquiry |
| ACPP-1723 | Human FGF 1 Protein, Sf9 (AC1723) | 2 µg | inquiry |
| ACPP-1677 | Mouse S100A8 Protein (AC1677) | 5 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.